Target intelligence / Profile preview

Mitochondrial carrier homolog 2 pseudogene 3 (MTCH2P3)

Target
MTCH2P3
Molecular classification
Other (pseudogene; not a functional protein)
01

Overview

MTCH2P3 is a processed pseudogene derived from the MTCH2 gene, which encodes a mitochondrial outer membrane protein involved in apoptosis, mitochondrial fusion, and metabolic regulation[1][3][4]. Unlike its parent gene MTCH2, MTCH2P3 does not code for a functional protein and is not known to participate in any biological processes, serve as a therapeutic target, or be associated with disease roles. Pseudogenes like MTCH2P3 generally lack transcriptional activity and functional protein products, and thus are not considered therapeutic targets. Sometimes, pseudogenes may exert regulatory effects on their parent genes via RNA mechanisms, but there is no evidence in the literature that MTCH2P3 does so. Key clarification: - MTCH2P3 is not a receptor, transporter, enzyme, or any functional molecule—it is a pseudogene and should be excluded from therapeutic target databases. - If you intended to refer to MTCH2, the mitochondrial carrier homolog 2 (sometimes called MIMP or SLC25A50), that is an active protein with roles in apoptosis, metabolism, and disease[1][3][4]. However, MTCH2P3 itself has no such functions. Summary of correctness: - MTCH2P3 is not a valid therapeutic target; it is a pseudogene, and document sources give no functional or disease-related information for this entry. - If the query is meant for the functional MTCH2 protein, refer to "Mitochondrial carrier homolog 2 (MTCH2)," not MTCH2P3.

Other names
MTCH2P3mitochondrial carrier 2 pseudogene 3MTCH2 pseudogene 3mitochondrial carrier homolog 2 pseudogene 3

Beyond the preview

Go deeper on Mitochondrial carrier homolog 2 pseudogene 3 (MTCH2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial carrier homolog 2 pseudogene 3 (MTCH2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call